Propanc Biopharma Files Registration Statement for Resale of 6.5 Million Shares of Common Stock

Filing content

Propanc Biopharma filed a registration statement for the resale of up to 6.5 million shares of common stock issuable upon conversion of Series C preferred stock and exercise of warrants.